Jul. 16, 2020
Publisher： ShiseidoShiseido Japan
Management / Financial Result
Product / Brand
Shiseido Begins General Sale of Hand Sanitizer (Designated Quasi Drug)
Specially Formulated for Dry Hands
-Available in Early August-
Shiseido Company, Limited (“Shiseido”) has reviewed and taken various measures, making use of its knowledge, technologies and facilities in a policy to “consider all possibilities available to us, as a cosmetics company, to suppress the spread of the Coronavirus infection and take immediate action.” (Shiseido President and CEO Masahiko Uotani)
Since April this year, Shiseido has been providing hand sanitizer (designated quasi drug) to medical institutions, which will also begin sale to the general public from the beginning of August. The product is alcohol-based hand sanitizer with “special attention to sensitive and raw hands”,” uniquely formulated by the cosmetics company Shiseido. The product will be distributed initially to stores (cosmetics specialty stores, drug stores, GMSs, DIY stores, and supermarkets) in Tokyo, Japan to satisfy high demand from consumers, followed by planned expansion of sales areas taking into consideration the market environment.
*The content of the release is correct as of the time of release, but please note that it may in some cases differ from the latest information.
Jan. 22, 2021
Regarding Reports on Transfer of Shiseido Personal Care Business
Jan. 15, 2021
Comes the debut of new brand EFFECTIM, revolutionary aging care expert*1 from Japan
Dec. 16, 2020
Shiseido Receives Prime Ministerial Award for Women Empowering Companies via Awards for Women Empowering Companies 2020